Current Status of Immunotherapy for Localized and Locally Advanced Renal Cell Carcinoma

Systemic therapy strategies in the setting of localized and locally advanced renal cell carcinoma (RCC) have continued to evolve in two directions: as adjuvant therapy (to reduce risk of recurrence or progression in high risk localized groups), or as neoadjuvant therapy as a strategy to render prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghali, Fady, Patel, Sunil H., Derweesh, Ithaar H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463563/
https://www.ncbi.nlm.nih.gov/pubmed/31057615
http://dx.doi.org/10.1155/2019/7309205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463563/
https://www.ncbi.nlm.nih.gov/pubmed/31057615
http://dx.doi.org/10.1155/2019/7309205

Ejemplares similares